184 related articles for article (PubMed ID: 29939072)
1. Plasma heat shock protein 90-alpha have an advantage in diagnosis of colorectal cancer at early stage.
Kasanga M; Liu L; Xue L; Song X
Biomark Med; 2018 Aug; 12(8):881-890. PubMed ID: 29939072
[TBL] [Abstract][Full Text] [Related]
2. Serum Cyr61 as a potential biomarker for diagnosis of colorectal cancer.
Song YF; Xu ZB; Zhu XJ; Tao X; Liu JL; Gao FL; Wu CL; Song B; Lin Q
Clin Transl Oncol; 2017 Apr; 19(4):519-524. PubMed ID: 27743169
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of carcinoembryonic antigen and carcinoma antigen 19-9 for colorectal carcinoma.
Zhang SY; Lin M; Zhang HB
Int J Clin Exp Pathol; 2015; 8(8):9404-9. PubMed ID: 26464695
[TBL] [Abstract][Full Text] [Related]
4. Plasma circular RNA panel acts as a novel diagnostic biomarker for colorectal cancer.
Lin J; Cai D; Li W; Yu T; Mao H; Jiang S; Xiao B
Clin Biochem; 2019 Dec; 74():60-68. PubMed ID: 31669510
[TBL] [Abstract][Full Text] [Related]
5. Plasma Heat Shock Protein 90alpha as a Biomarker for the Diagnosis of Liver Cancer: An Official, Large-scale, and Multicenter Clinical Trial.
Fu Y; Xu X; Huang D; Cui D; Liu L; Liu J; He Z; Liu J; Zheng S; Luo Y
EBioMedicine; 2017 Oct; 24():56-63. PubMed ID: 28939487
[TBL] [Abstract][Full Text] [Related]
6. Plasma levels of heat shock protein 90 alpha associated with lung cancer development and treatment responses.
Shi Y; Liu X; Lou J; Han X; Zhang L; Wang Q; Li B; Dong M; Zhang Y
Clin Cancer Res; 2014 Dec; 20(23):6016-22. PubMed ID: 25316816
[TBL] [Abstract][Full Text] [Related]
7. A novel pan-cancer biomarker plasma heat shock protein 90alpha and its diagnosis determinants in clinic.
Liu W; Li J; Zhang P; Hou Q; Feng S; Liu L; Cui D; Shi H; Fu Y; Luo Y
Cancer Sci; 2019 Sep; 110(9):2941-2959. PubMed ID: 31343810
[TBL] [Abstract][Full Text] [Related]
8. Fecal CEA Has an Advantage in the Diagnosis of Colorectal Cancer at Early Stage.
Li L; Xing S; Wu M; Ao Y; Zheng X; Cai R; Han R; Li J; Li X; Zeng Q
Cancer Control; 2021; 28():10732748211048292. PubMed ID: 34615391
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of carcinoembryonic antigen (CEA), epidermal growth factor receptor (EGFR), epithelial cell adhesion molecule EpCAM (GA733-2), and carbohydrate antigen 19-9 (CA 19-9) levels in colorectal cancer patients and correlation with clinicopathological characteristics.
Mourtzikou A; Stamouli M; Kroupis C; Christodoulou S; Skondra M; Kastania A; Pectasides D; Athanasas G; Dimas C
Clin Lab; 2012; 58(5-6):441-8. PubMed ID: 22783573
[TBL] [Abstract][Full Text] [Related]
10. Circulating miR-338-5p is a potential diagnostic biomarker in colorectal cancer.
Bilegsaikhan E; Liu HN; Shen XZ; Liu TT
J Dig Dis; 2018 Jul; 19(7):404-410. PubMed ID: 29952077
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNAs LOC285194, RP11-462C24.1 and Nbla12061 in serum provide a new approach for distinguishing patients with colorectal cancer from healthy controls.
Wang C; Yu J; Han Y; Li L; Li J; Li T; Qi P
Oncotarget; 2016 Oct; 7(43):70769-70778. PubMed ID: 27683121
[TBL] [Abstract][Full Text] [Related]
12. Role of serum Metadherin mRNA expression in the diagnosis and prediction of survival in patients with colorectal cancer.
Abdel Ghafar MT; Gharib F; Abdel-Salam S; Elkhouly RA; Elshora A; Shalaby KH; El-Guindy D; El-Rashidy MA; Soliman NA; Abu-Elenin MM; Allam AA
Mol Biol Rep; 2020 Apr; 47(4):2509-2519. PubMed ID: 32088817
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic and prognostic value of plasma heat shock protein 90alpha in gastric cancer.
Liang XQ; Li KZ; Li Z; Xie MZ; Tang YP; Du JB; Huang Y; Li JL; Hu BL
Int Immunopharmacol; 2021 Jan; 90():107145. PubMed ID: 33162344
[TBL] [Abstract][Full Text] [Related]
14. Utility and specificity of plasma heat shock protein 90 alpha, CEA, and CA199 as the diagnostic test in colorectal cancer liver metastasis.
Ding Q; Sun Y; Zhang J; Yao Y; Huang D; Jiang Y
J Gastrointest Oncol; 2022 Oct; 13(5):2497-2504. PubMed ID: 36388698
[TBL] [Abstract][Full Text] [Related]
15. SALL4 as a new biomarker for early colorectal cancers.
Ardalan Khales S; Abbaszadegan MR; Abdollahi A; Raeisossadati R; Tousi MF; Forghanifard MM
J Cancer Res Clin Oncol; 2015 Feb; 141(2):229-35. PubMed ID: 25156818
[TBL] [Abstract][Full Text] [Related]
16. Serum haptoglobin as a novel molecular biomarker predicting colorectal cancer hepatic metastasis.
Sun L; Hu S; Yu L; Guo C; Sun L; Yang Z; Qi J; Ran Y
Int J Cancer; 2016 Jun; 138(11):2724-31. PubMed ID: 26756179
[TBL] [Abstract][Full Text] [Related]
17. Identification and verification of heat shock protein 60 as a potential serum marker for colorectal cancer.
Hamelin C; Cornut E; Poirier F; Pons S; Beaulieu C; Charrier JP; Haïdous H; Cotte E; Lambert C; Piard F; Ataman-Önal Y; Choquet-Kastylevsky G
FEBS J; 2011 Dec; 278(24):4845-59. PubMed ID: 21973086
[TBL] [Abstract][Full Text] [Related]
18. Circulating midkine in malignant and non-malignant colorectal diseases.
Krzystek-Korpacka M; Diakowska D; Neubauer K; Gamian A
Cytokine; 2013 Oct; 64(1):158-64. PubMed ID: 23899719
[TBL] [Abstract][Full Text] [Related]
19. The Usefulness of Vitamin K-Dependent Proteins in the Diagnosis of Colorectal Carcinoma.
Perné MG; Sitar-Tăut AV; Orășan OH; Negrean V; Vlad CV; Alexescu TG; Milaciu MV; Ciumărnean L; Togănel RD; Petre GE; Șimon I; Crăciun A
Int J Mol Sci; 2024 May; 25(9):. PubMed ID: 38732222
[TBL] [Abstract][Full Text] [Related]
20. The role of carcinoembryonic antigen as an assessment tool for predicting disease severity among patients with colorectal cancer in resource-poor setting of Kwazulu-Natal, South Africa.
Naicker YD; Moolla Z; Madiba T
Pan Afr Med J; 2021; 39():185. PubMed ID: 34584610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
